Search

Your search keyword '"Manoharan, Muthiah"' showing total 845 results

Search Constraints

Start Over You searched for: Author "Manoharan, Muthiah" Remove constraint Author: "Manoharan, Muthiah" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
845 results on '"Manoharan, Muthiah"'

Search Results

1. Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAs.

3. Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates

4. Conformation matters: siRNAs with antisense strands with 5'-(E)-vinyl-phosphonate-A-L-LNA elicit stronger RNAi-mediated gene silencing than those with 5'-(E)-vinyl-phosphonate-LNA.

5. Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates

10. Multivalent N‑Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

14. Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAs

22. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

23. Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways

26. Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy

28. Challenges and Opportunities for Nucleic Acid Therapeutics

29. Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes. Molecules 2022, 27, 3944

31. Role of a “Magic” Methyl: 2′-Deoxy-2′-α-F-2′-β-C-methyl Pyrimidine Nucleotides Modulate RNA Interference Activity through Synergy with 5′-Phosphate Mimics and Mitigation of Off-Target Effects

32. From bench to bedside: Improving the clinical safety of GalNAc–siRNA conjugates using seed-pairing destabilization

36. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes

37. Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes. Molecules 2022, 27, 3944

38. An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia

39. Widespread suppression of huntingtin with convection-enhanced delivery of siRNA

41. Therapeutic RNAi Targeting PCSK9 Acutely Lowers Plasma Cholesterol in Rodents and LDL Cholesterol in Nonhuman Primates

42. RNAs Containing Carbocyclic Ribonucleotides

47. Expanding the Reach of RNAi Therapeutics with Next Generation Lipophilic siRNA Conjugates

48. Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs

49. Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing

50. Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo

Catalog

Books, media, physical & digital resources